000 01551 a2200457 4500
005 20250513140843.0
264 0 _c19980422
008 199804s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(97)01387-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElmer, D S
245 0 0 _aMetabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
_h[electronic resource]
260 _bTransplantation proceedings
_cMar 1998
300 _a523-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCyclosporine
_xadministration & dosage
650 0 4 _aDiabetes Complications
650 0 4 _aDiabetes Mellitus
_xmetabolism
650 0 4 _aDrainage
650 0 4 _aFemale
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGraft Rejection
_xprevention & control
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xetiology
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aPancreas Transplantation
650 0 4 _aPortal System
_xsurgery
650 0 4 _aTacrolimus
_xadministration & dosage
650 0 4 _aTransplantation, Homologous
700 1 _aAbdulkarim, A B
700 1 _aFraga, D
700 1 _aShokouh-Amiri, H
700 1 _aStratta, R J
700 1 _aHathaway, D K
700 1 _aReddy, K
700 1 _aGaber, A O
773 0 _tTransplantation proceedings
_gvol. 30
_gno. 2
_gp. 523-4
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(97)01387-0
_zAvailable from publisher's website
999 _c9499765
_d9499765